Arthritis: Types, Symptoms, and Comprehensive Treatment Guide: Symptoms, Causes & Monitoring Guide

Understanding Arthritis

Arthritis is not a single disease—it's an informal way of referring to joint pain or joint disease. More than 100 different types of arthritis and related conditions exist, affecting over 350 million people worldwide and 54 million adults in the U.S. While commonly associated with aging, arthritis affects people of all ages, including children.

The term "arthritis" literally means joint inflammation (arthro = joint, itis = inflammation). However, not all types of arthritis involve significant inflammation—the spectrum ranges from purely degenerative (wear-and-tear) to autoimmune-driven inflammatory conditions.

The Impact of Arthritis

Arthritis is the leading cause of disability in the U.S., responsible for more than 100 million lost workdays annually. It significantly impacts quality of life: mental health, sleep, physical function, and social participation. Early diagnosis and appropriate treatment can prevent joint damage and disability.

Major Types of Arthritis

Osteoarthritis (OA) - "Wear and Tear"

Prevalence : Most common type, affecting ~32 million U.S. adults

Pathology : Breakdown of joint cartilage, bone remodeling, osteophyte (bone spur) formation. NOT purely wear-and-tear—active inflammatory processes contribute.

Risk Factors :

Age (primary risk factor)

Obesity (knee OA: 1 lb weight gain = 4 lb load increase on knees)

Joint injury (ACL tear, meniscus injury)

Repetitive stress (occupational, sports)

Genetics (heritability ~40-60%)

Female sex (higher prevalence after menopause)

Typical Presentation :

Gradual onset (months to years)

Deep, aching joint pain worsened by use, improved with rest

Morning stiffness ＜30 minutes

Joint swelling, crepitus (crackling sensation)

Functional limitation (difficulty climbing stairs, opening jars)

Rheumatoid Arthritis (RA) - Autoimmune

Prevalence : ~1.5 million U.S. adults (0.6% of population)

Pathology : Autoimmune attack on synovium (joint lining), causing inflammation, cartilage damage, bone erosion. Systemic disease affecting multiple organ systems.

Risk Factors :

Female sex (2-3x more common in women)

Age 40-60 (can occur at any age)

Genetics (HLA-DRB1 shared epitope)

Smoking (doubles risk, worse outcomes)

Obesity (reduces treatment response)

Periodontal disease (possible microbial trigger)

Typical Presentation :

Symmetric joint involvement (hands, wrists, feet)

Prolonged morning stiffness (＞1 hour)

Constitutional symptoms: fatigue, low-grade fever, malaise

Rheumatoid nodules (firm lumps under skin, ~20% of patients)

Systemic manifestations: lung disease, heart disease, osteoporosis

Gout - Crystal-Induced

Prevalence : ~9 million U.S. adults (3.9% of population)

Pathology : Deposition of monosodium urate crystals in joints, triggering intense inflammatory response. Results from hyperuricemia (elevated uric acid).

Risk Factors :

Male sex (until menopause, then risk equalizes)

Obesity, metabolic syndrome

Diet high in purines (red meat, seafood, alcohol—especially beer)

Genetics (SLC2A9, ABCG2 variants)

Kidney dysfunction (reduced uric acid excretion)

Diuretics (thiazides, loop diuretics)

Typical Presentation :

Sudden, severe joint pain (often at night)

First MTP joint (big toe) affected in 50% (podagra)

Intense inflammation: red, hot, swollen, extremely tender

Attacks last 3-10 days without treatment, then resolve completely

Recurrent attacks lead to chronic gouty arthritis, tophi (urate deposits)

Arthritis Progression Timeline

Factor

Effect

What to Do

Always tell your doctor about medications, supplements, and recent health events before testing.

Diagnosis

Clinical Evaluation

Joint Examination :

Inspection: Swelling, redness, deformity, alignment

Palpation: Warmth, tenderness, effusion

Range of motion: Active and passive, crepitus

Stability: Ligament testing

Functional assessment: Gait, grip strength, timed activities

Laboratory Tests :

| Test | Osteoarthritis | Rheumatoid Arthritis | Gout | |------|----------------|----------------------|------| | ESR/CRP | Normal/mildly elevated | Elevated | Elevated during attack | | Rheumatoid factor (RF) | Negative | Positive in 70-80% | Negative | | Anti-CCP | Negative | Positive in 70% (more specific) | Negative | | Uric acid | Normal | Normal | Elevated (but can be normal during attack) | | Synovial fluid | Non-inflammatory | Inflammatory | Crystals visible |

Imaging :

X-ray : First-line for OA (joint space narrowing, osteophytes, subchondral sclerosis)

Ultrasound : Detects synovitis, erosions, crystals (useful for RA, gout)

MRI : Early OA (bone marrow lesions), RA (synovitis, erosions before X-ray)

CT : Preoperative planning, complex joint anatomy

Diagnostic Criteria :

ACR/EULAR Criteria for RA : Requires ≥6 points from joint involvement, serology, acute-phase reactants, duration

ACR Criteria for Gout : Presence of urate crystals in synovial fluid is definitive

Treatment Strategies

Osteoarthritis Management

Nonpharmacologic :

Weight loss : 10% weight loss → 50% reduction in knee OA pain

Exercise : Physical therapy, low-impact activities (walking, swimming, cycling)

Bracing/orthotics : Unloader braces for knee OA, shoe inserts

Hot/cold therapy : Heat for stiffness, ice for inflammation

Pharmacologic :

Topical NSAIDs (diclofenac): First-line for hand/knee OA (minimal systemic absorption)

Oral NSAIDs : Effective but GI, renal, cardiovascular risks

Acetaminophen : Modest benefit, safer than NSAIDs

Intra-articular injections : Corticosteroids (short-term relief), hyaluronic acid (viscosupplementation, mixed evidence)

Duloxetine : SNRI effective for chronic OA pain

Surgical :

Arthroscopy : Generally NOT recommended (no better than sham surgery for most)

Osteotomy : Joint-preserving surgery for young patients with malalignment

Joint replacement : Gold standard for end-stage OA (knee, hip, shoulder) Success rate: 90-95% patient satisfaction at 10 years Recovery: 3-6 months for full function Lifespan: 15-20 years (knee), 20-25 years (hip)

Success rate: 90-95% patient satisfaction at 10 years

Recovery: 3-6 months for full function

Lifespan: 15-20 years (knee), 20-25 years (hip)

Rheumatoid Arthritis Management

Treat-to-Target Approach :

Goal: Remission or low disease activity

Tight control: Frequent monitoring, medication adjustment until goal achieved

DMARDs (Disease-Modifying Antirheumatic Drugs) :

| Class | Examples | Onset | Monitoring | |-------|----------|-------|------------| | Conventional synthetic | Methotrexate (first-line), Hydroxychloroquine, Sulfasalazine, Leflunomide | 6-8 weeks | CBC, LFTs, renal | | Biologic | TNF inhibitors (adalimumab, etanercept), IL-6 inhibitors (tocilizumab), B-cell depletion (rituximab) | 2-4 weeks | TB screening, infection risk | | Targeted synthetic | JAK inhibitors (tofacitinib, upadacitinib) | 2 weeks | CBC, lipids, infection risk |

Glucocorticoids :

Bridge therapy while waiting for DMARDs to work

Lowest effective dose for shortest duration

Long-term side effects: osteoporosis, diabetes, cataracts, infection

Nonpharmacologic :

Physical therapy: Joint protection techniques, strengthening

Occupational therapy: Assistive devices, joint protection strategies

Smoking cessation: Improves treatment response, reduces cardiovascular risk

Gout Management

Acute Attack Treatment (start within 24 hours for best effect):

NSAIDs : Indomethacin, naproxen (first-line for most)

Colchicine : Effective if given early (dosing: 1.2 mg initially, then 0.6 mg 1 hour later, then 0.6 mg q8-12h)

Glucocorticoids : Prednisone 30-40 mg daily × 5-10 days, or intra-articular injection

Urate-Lowering Therapy (ULT) :

Indication : Frequent attacks (≥2/year), tophi, urate nephropathy, kidney stones

First-line : Allopurinol (starting at 100 mg daily, titrate to goal uric acid ＜6 mg/dL)

Alternative : Febuxostat (for allopurinol-intolerant or CKD)

Probenecid : Increases uric acid excretion (for underexcreters, normal renal function)

Lifestyle :

Limit purine-rich foods (red meat, organ meats, shellfish)

Avoid alcohol (especially beer, spirits)

Limit fructose-sweetened beverages

Weight loss if overweight

Stay hydrated

Gout Flare During Urate-Lowering Therapy

Starting ULT can precipitate gout flares due to mobilization of urate crystals. Prophylaxis with low-dose colchicine (0.6 mg daily) or NSAID for 6 months is recommended. Don't stop ULT during a flare—instead, treat the inflammation and continue ULT.

Lifestyle Modifications for All Types

Exercise

Low-impact activities : Walking, swimming, cycling, tai chi

Range of motion : Preserve joint mobility

Strengthening : Support and stabilize joints

Avoid : High-impact activities (running, jumping) on affected joints

Weight Management

Target BMI 18.5-24.9

Even 5-10% weight loss significantly reduces joint load and pain

Diet: Mediterranean diet (anti-inflammatory, heart-healthy)

Joint Protection

Use larger joints when possible (carry load on forearms, not hands)

Distribute load (use two hands, backpack vs shoulder bag)

Avoid prolonged static positions

Use assistive devices (jar openers, grab bars, shoehorns)

Related Conditions

Lupus : Another autoimmune arthritis

Psoriatic Arthritis : Inflammatory arthritis with psoriasis

Fibromyalgia : Chronic widespread pain, not true arthritis

FAQ

Can cracking my knuckles cause arthritis?

What's the difference between osteoarthritis and rheumatoid arthritis?

When should I consider joint replacement?

Can diet cure arthritis?

Is gout only caused by diet?

References

[ 1 ] American College of Rheumatology. 2023 Guideline for the Management of Osteoarthritis. Arthritis & Rheumatology, 2023. https://doi.org/10.1002/art.42000

[ 2 ] Osteoarthritis Research Society International. 2024 Guidelines for Osteoarthritis Management. Osteoarthritis and Cartilage, 2024. https://doi.org/10.1016/j.joca.2024.01.002

[ 3 ] Centers for Disease Control and Prevention. Arthritis-Related Statistics. https://www.cdc.gov/arthritis/

[ 4 ] European League Against Rheumatism. 2023 Rheumatoid Arthritis Management Recommendations. Annals of the Rheumatic Diseases, 2023. https://doi.org/10.1136/ard-2023-124567

[ 5 ] FitzGerald JD et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care & Research, 2020. https://doi.org/10.1002/acr.24373

Need a monitoring plan?

Track your labs, vitals, and symptoms in one dashboard with reminders.